603233.SH
DaShenLin Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 17.36
−1.70%Forward multiples
Based on analyst estimates
- P/E forward
- 14.28x
- P/E 2026E
- 14.08x
- P/E 2027E
- 12.19x
- P/E 2028E
- 10.80x
- P/S forward
- 0.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.01x
- PEG TTM
- 1.17x
- Price / book
- 2.77x
- Price / sales
- 0.76x
- Price / cash flow
- 4.60x
Enterprise value
- Enterprise value
- CNY 18.0B
- EV / sales
- 0.65x
- EV / EBITDA
- 7.50x
- EV / EBIT
- 9.37x
- Market cap
- CNY 19.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026